Press Releases from THELANSIS KNOWLEDGE PARTNERS LLP (1 total)
Idiopathic pulmonary fibrosis (IPF): Market Outlook and Competitive Landscape Re …
LAPS Triple Agonist (HM15211) of Hanmi Pharmaceutical has granted Orphan drug designation for treating Idiopathic pulmonary fibrosis (IPF). Pulmonary fibrosis occurs in the interstitium, which is the lung tissue that provides the scaffolding for the alveoli. Fibrosis thickens the interstitium, making the alveoli stiff so that they are unable to fully expand and hold as much air as they normally should. This thickening also limits the passage of oxygen through…
Go To Page: 1
